In what's on pace to be the biggest Boston office deal of 2019, local investment firm Rockpoint Group agreed to buy 100 Summer St. for about $800 million in a move that shows the city's commercial property demand isn't limited to being the nation's biotechnology real estate capital.
Major Office Sale Shows This City's More Than Just the US Biotech Capital
Local Firm Rockpoint Agrees to $800 Million Purchase From Blackstone
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In